43 results
DEFM14A
FUSN
Fusion Pharmaceuticals Inc
25 Apr 24
Proxy related to merger
4:13pm
-19 or intended to address the consequences of the COVID-19 pandemic.
CBCA means the Canada Business Corporations Act, as amended.
Change
PREM14A
FUSN
Fusion Pharmaceuticals Inc
10 Apr 24
Preliminary proxy related to merger
4:42pm
and regulations related to COVID-19 or intended to address the consequences of the COVID-19 pandemic.
CBCA means the Canada Business Corporations Act, as amended
DEFA14A
FUSN
Fusion Pharmaceuticals Inc
19 Mar 24
Additional proxy soliciting materials
6:25am
, guidance, rules and regulations related to COVID-19 or intended to address the consequences of the COVID-19 pandemic.
CBCA means the Canada Business
8-K
EX-2.1
FUSN
Fusion Pharmaceuticals Inc
19 Mar 24
Voting and Support Agreement
6:24am
-19 or intended to address the consequences of the COVID-19 pandemic.
CBCA means the Canada Business Corporations Act, as amended.
Change
8-K
EX-10.1
7zqyxcgg v2k78moa
16 Feb 24
Entry into a Material Definitive Agreement
4:05pm
424B5
nvhnjej49xnv ud
19 Jan 24
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
ci0srn 4fa0e6e
9 Aug 22
Fusion Pharmaceuticals Announces Second Quarter 2022 Financial Results and Clinical Program Updates
7:31am
8-K
EX-99.1
sjo6j9u50j3g p64
10 May 22
Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results and Clinical Program Updates
7:30am
8-K
EX-99.1
pzpb05nvf23ser 0k
17 Mar 22
Fusion Pharmaceuticals Announces Fourth Quarter
7:30am